WestEnd Capital Management »

Sage Therapeutics shares owned by WestEnd Capital Management

Quarter-by-quarter ownership of Sage Therapeutics (SAGE) shares owned by WestEnd Capital Management from 13F filings

Historical chart of WestEnd Capital Management investment in Sage Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sage Therapeutics held by WestEnd Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sage Therapeutics by WestEnd Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $0 0 0.00

More positions owned by WestEnd Capital Management

NVIDIA Corporation (NVDA)
Facebook Inc cl a (META)
Uber Technologies (UBER)
Freeport-McMoRan Copper & Gold (FCX)
Microsoft Corporation (MSFT)
Energy Transfer Equity (ET)
Eli Lilly & Co. (LLY)
Quanta Services (PWR)
Cameco Corporation (CCJ)
Fluor Corporation (FLR)
Carnival Corporation (CCL)
Amazon (AMZN)
Super Micro Computer (SMCI)
Netflix (NFLX)
Jacobs Engineering Group (J)

View all positions for WestEnd Capital Management

Top funds holding Sage Therapeutics

Wellington Management Company
Vanguard Group
Bellevue Group
Jpmorgan Chase & Co
Deutsche Bank Aktiengesellschaft
Palo Alto Investors
Dimensional Fund Advisors
Samlyn Capital
Jacobs Levy Equity Management
Citadel Advisors
T. Rowe Price Associates
Goldman Sachs Group
Cowen And Company
Fisher Investments
Charles Schwab Investment Management

View all funds holding Sage Therapeutics